Animal Model to Study Improved Measles Vaccines - Albert Osterhaus

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research Project (R01)
Project #: 5R01AI035144-03
Application #: 2004038
Study Section: AIDS and Related Research Study Section 1 (ARRA)

Project Start: 1994-02-01
Project End: 1998-01-31
Budget Start: 1996-02-01
Budget End: 1997-01-31
Support Year: 3
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: National Institute of Pub Health/Env Hyg(Rivm)
Department
Type
DUNS #

City: Bilthoven
State
Country: Netherlands
Zip Code

Related projects


NIH 1997 R01 AI	Animal Model to Study Improved Measles Vaccines Osterhaus, Albert / National Institute of Pub Health/Env Hyg(Rivm)
NIH 1996 R01 AI	Animal Model to Study Improved Measles Vaccines Osterhaus, Albert / National Institute of Pub Health/Env Hyg(Rivm)
NIH 1995 R01 AI	Animal Model to Study Improved Measles Vaccines Osterhaus, Albert / National Institute of Pub Health/Env Hyg(Rivm)
NIH 1994 R01 AI	Animal Model to Study Improved Measles Vaccines Osterhaus, Albert / National Institute of Pub Health/Env Hyg(Rivm)

Publications

Stittelaar, K J; Wyatt, L S; de Swart, R L et al. (2000) Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol 74:4236-43

Verjans, G M; Remeijer, L; van Binnendijk, R S et al. (1998) Identification and characterization of herpes simplex virus-specific CD4+ T cells in corneas of herpetic stromal keratitis patients. J Infect Dis 177:484-8

van Binnendijk, R S; Poelen, M C; van Amerongen, G et al. (1997) Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis 175:524-32

Comments

Be the first to comment on Albert Osterhaus's grant